Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
Clinical trial NCT04572165 · COMPLETED
Trial details
- NCT number
- NCT04572165
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-26
- Primary completion
- 2025-11-25
- Enrollment
- 194928
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.